HK1056168A1 - Imidazole derivatives, production method thereof and use thereof - Google Patents

Imidazole derivatives, production method thereof and use thereof

Info

Publication number
HK1056168A1
HK1056168A1 HK03108376A HK03108376A HK1056168A1 HK 1056168 A1 HK1056168 A1 HK 1056168A1 HK 03108376 A HK03108376 A HK 03108376A HK 03108376 A HK03108376 A HK 03108376A HK 1056168 A1 HK1056168 A1 HK 1056168A1
Authority
HK
Hong Kong
Prior art keywords
production method
imidazole derivatives
imidazole
derivatives
production
Prior art date
Application number
HK03108376A
Other languages
English (en)
Inventor
Akihiro Tasaka
Takenori Hitaka
Nobuyuki Matsunaga
Masami Kusaka
Mari Adachi
Isao Aoki
Akio Ojida
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of HK1056168A1 publication Critical patent/HK1056168A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
HK03108376A 2000-11-17 2003-11-17 Imidazole derivatives, production method thereof and use thereof HK1056168A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000351780 2000-11-17
JP2001247618 2001-08-17
JP2001336880 2001-11-01
PCT/JP2001/010002 WO2002040484A2 (en) 2000-11-17 2001-11-16 Novel imidazole derivatives, production method thereof and use thereof

Publications (1)

Publication Number Publication Date
HK1056168A1 true HK1056168A1 (en) 2004-02-06

Family

ID=27345219

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108376A HK1056168A1 (en) 2000-11-17 2003-11-17 Imidazole derivatives, production method thereof and use thereof

Country Status (27)

Country Link
US (1) US7141598B2 (el)
EP (2) EP1334106B1 (el)
JP (2) JP3753971B2 (el)
KR (3) KR20080002929A (el)
CN (3) CN100572363C (el)
AR (1) AR034854A1 (el)
AT (2) ATE533768T1 (el)
AU (3) AU1429602A (el)
BR (1) BR0115306B1 (el)
CA (1) CA2429133C (el)
CY (1) CY1105423T1 (el)
DE (1) DE60119963T2 (el)
DK (1) DK1334106T3 (el)
ES (1) ES2260303T3 (el)
HK (1) HK1056168A1 (el)
HU (1) HU229408B1 (el)
IL (2) IL155624A0 (el)
MX (1) MXPA03004347A (el)
MY (1) MY134929A (el)
NO (1) NO326366B1 (el)
NZ (1) NZ526387A (el)
PE (1) PE20020596A1 (el)
PL (1) PL204934B1 (el)
PT (1) PT1334106E (el)
SI (1) SI1334106T1 (el)
TW (1) TWI306099B (el)
WO (1) WO2002040484A2 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2700690C (en) * 2002-01-10 2013-09-10 Takeda Pharmaceutical Company Limited Process for producing reformatsky reagent in stable form
WO2004075890A1 (ja) * 2003-02-26 2004-09-10 Takeda Pharmaceutical Company 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾ－ル誘導体の安定化方法
JP4745616B2 (ja) * 2003-02-26 2011-08-10 武田薬品工業株式会社 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法
EP1607092A4 (en) * 2003-03-17 2010-12-15 Takeda Pharmaceutical CONTROLLED RELEASE COMPOSITIONS
JP4837895B2 (ja) * 2003-03-17 2011-12-14 武田薬品工業株式会社 放出制御組成物
AU2005243240B2 (en) * 2004-05-03 2012-03-15 Janssen Pharmaceutica N.V. Novel indole derivatives as selective androgen receptor modulators (SARMS)
TW200616623A (en) * 2004-05-28 2006-06-01 Speedel Experimenta Ag Organic compounds
EP1854463A4 (en) * 2005-03-03 2011-03-23 Takeda Pharmaceutical COMPOSITION WITH CONTROLLED RELEASE
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
AR056888A1 (es) * 2005-12-09 2007-10-31 Speedel Experimenta Ag Derivados de heterociclil imidazol
US7655683B2 (en) * 2006-02-10 2010-02-02 Janssen Pharmaceutica Nv Imidazolopyrazole derivatives useful as selective androgen receptor modulators
AR060225A1 (es) * 2006-03-31 2008-06-04 Speedel Experimenta Ag Proceso para preparar 6,7- dihidro-5h-imidazo (1,5-a) piridin -8- ona
CL2008003198A1 (es) * 2007-10-29 2009-12-18 Takeda Pharmaceuticals Co Composicion farmaceutica que comprende un inhibidor de esteroide c17,20 liasa; y uso para el tratamiento de cancer de prostata independiente de androgenos.
JOP20190231A1 (ar) * 2009-01-15 2017-06-16 Incyte Corp طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
UY33740A (es) * 2010-11-18 2012-05-31 Takeda Pharmaceutical Método para tratar el cáncer de mama y cáncer de ovarios
BR112013022010A2 (pt) 2011-04-01 2016-11-29 Takeda Pharmaceuticals Co preparação sólida, e, método de estabilização de um composto ou um sal do mesmo
MX2013014009A (es) 2011-06-15 2014-03-12 Takeda Pharmaceutical Metodo de produccion de derivados de imidazol.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
AU606677B2 (en) 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US4966898A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
JPH06507355A (ja) 1991-03-01 1994-08-25 エレクトロスタティック　テクノロジー　インコーポレーテッド 回路板用薄層板等を製造するための粉体コーティング法
CA2127689A1 (en) 1992-01-27 1993-08-05 Marcel A. C. Janssen Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
US5457102A (en) 1994-07-07 1995-10-10 Janssen Pharmaceutica, N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
JP2742331B2 (ja) 1992-03-31 1998-04-22 ブリテイツシユ・テクノロジー・グループ・リミテツド 癌治療に有用な１７位置換ステロイド
GB9310635D0 (en) 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
KR960704852A (ko) 1993-09-30 1996-10-09 오노다 마사요시 아졸 유도체 및 이의 약제학적 조성물 (Azole derivative and pharmaceutical composition thereof)
WO1996014090A1 (en) 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
AU6015796A (en) 1995-06-14 1997-01-15 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
ATE231128T1 (de) 1997-02-21 2003-02-15 Takeda Chemical Industries Ltd Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
NZ501822A (en) 1997-10-02 2001-12-21 Yukijirushi Nyugyo Kabushiki K Therapeutic agents for male and female sex hormone dependent diseases
DE69924717T2 (de) 1998-04-23 2006-03-09 Takeda Pharmaceutical Co. Ltd. Naphthalene derivate ,ihre herstellung und verwendung
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion

Also Published As

Publication number Publication date
EP1681290A2 (en) 2006-07-19
PT1334106E (pt) 2006-08-31
CN1474819A (zh) 2004-02-11
BR0115306A (pt) 2004-02-10
NO326366B1 (no) 2008-11-17
DK1334106T3 (da) 2006-09-18
CN1900079A (zh) 2007-01-24
US20040033935A1 (en) 2004-02-19
KR20080002929A (ko) 2008-01-04
BR0115306B1 (pt) 2013-12-24
AU2002214296C1 (en) 2006-04-13
CY1105423T1 (el) 2010-04-28
ES2260303T3 (es) 2006-11-01
KR100725442B1 (ko) 2007-06-07
HUP0400549A3 (en) 2004-09-28
KR20030048156A (ko) 2003-06-18
HU229408B1 (hu) 2013-12-30
IL155624A (en) 2006-12-31
ATE327237T1 (de) 2006-06-15
EP1334106A2 (en) 2003-08-13
CN1680336A (zh) 2005-10-12
PE20020596A1 (es) 2002-08-13
IL155624A0 (en) 2003-11-23
AU1429602A (en) 2002-05-27
WO2002040484A3 (en) 2002-09-26
EP1681290A3 (en) 2006-07-26
CA2429133C (en) 2009-08-18
AR034854A1 (es) 2004-03-24
CN1329394C (zh) 2007-08-01
JP3753971B2 (ja) 2006-03-08
CN100572363C (zh) 2009-12-23
MXPA03004347A (es) 2004-05-04
NZ526387A (en) 2004-02-27
TWI306099B (en) 2009-02-11
EP1334106B1 (en) 2006-05-24
SI1334106T1 (sl) 2006-10-31
WO2002040484A2 (en) 2002-05-23
NO20032234L (no) 2003-07-16
JP2003201282A (ja) 2003-07-18
AU2005225035B2 (en) 2007-02-22
AU2005225035A1 (en) 2005-11-10
JP2006045239A (ja) 2006-02-16
DE60119963D1 (de) 2006-06-29
HUP0400549A2 (hu) 2004-06-28
PL204934B1 (pl) 2010-02-26
ATE533768T1 (de) 2011-12-15
JP4427496B2 (ja) 2010-03-10
NO20032234D0 (no) 2003-05-16
MY134929A (en) 2008-01-31
KR20050105287A (ko) 2005-11-03
AU2002214296B2 (en) 2005-09-29
PL362766A1 (en) 2004-11-02
KR100809899B1 (ko) 2008-03-10
EP1681290B1 (en) 2011-11-16
DE60119963T2 (de) 2006-10-05
US7141598B2 (en) 2006-11-28
CA2429133A1 (en) 2002-05-23
EP1681290B9 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
PL365787A1 (en) Heterocyclic compounds, their production and use
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
HUP0303715A3 (en) Aqueous adhesive system, method for the production and use thereof
HK1056168A1 (en) Imidazole derivatives, production method thereof and use thereof
HK1075650A1 (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HUP0302065A3 (en) Chromanone derivatives, production and use thereof
PL366168A1 (en) Impregnate, method for the production and use thereof
AU2796602A (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
IL152612A0 (en) Cyclipostins, a method for their production and the use of the same
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
IL151082A0 (en) Thienopyridine derivatives, their production and use
AU2001262229A1 (en) Cyclipostins, a method for their production and the use of the same
HU0001397D0 (en) 3-amino-3-arylpropan-1-ol derivatives, production and use thereof
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use
AU2795202A (en) Klainetin and derivatives thereof, method for their production and the use of the same
AU6730001A (en) Component, method for production and use thereof
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same
IL151216A0 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
SI1456212T1 (sl) Derivati 6-aminomorfinana, postopek za njihovo izdelavo in njihova uporaba
SI1372670T1 (en) Caloporoside derivatives, methods for the production thereof and their use
IL141804A0 (en) Benzotriazole-1-yl-uronium derivatives, process for their preparation and use thereof

Legal Events

Date Code Title Description
CHRG Changes in the register
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191122